Aptevo Therapeutics Competitors and Similar CompaniesClear all
Aptevo Therapeutics's competitors and similar companies include Olema Oncology, Rain Therapeutics, Odyssey Therapeutics and ImmunoGen.
 Aptevo Therapeutics Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. |  Olema Oncology Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers. |  Rain Therapeutics Rain Therapeutics is a biotechnology company focused on developing small molecule targeted therapeutics for cancer patients. |  Odyssey Therapeutics Odyssey Therapeutics is a company that develops precision immunomodulators and oncology medicines. |  ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. | |
Founding Date | Founding Date 2016 | Founding Date 2007 | Founding Date 2017 | Founding Date 2021 | Founding Date 1981 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Seattle, US HQ | Locations San Francisco, US HQ San Francisco, US | Locations Newark, US HQ | Locations Boston, US HQ Frankfurt Am Main, DE Ann Arbor, US San Diego, US | Locations Waltham, US HQ |
Employees | Employees 1182% decrease | Employees 9630% increase | Employees 6343% increase | Employees 1481% decrease | Employees 277161% increase |
Valuation ($) | Valuation ($) 4.1 m | Valuation ($) 679.2 m | Valuation ($) 44 m | Valuation ($) N/A | Valuation ($) 8.7 b |
Financial | |||||
Net income | Net income ($26m) (FY, 2025) | Net income ($162.5m) (FY, 2025) | Net income ($75.7m) (FY, 2022) | Net income N/A | Net income ($222.9m) (FY, 2022) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 145.1m | Total funding raised $ 82.4m | Total funding raised $ 386m | Total funding raised $ 56m |
For sources of this data, please see the company profile
View Company Profiles
Olema Oncology
HQ
San Francisco, US
Employees
96↑ 30% increase
Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.
View companyRain Therapeutics
HQ
Newark, US
Employees
63↑ 43% increase
Rain Therapeutics is a biotechnology company focused on developing small molecule targeted therapeutics for cancer patients.
View companyOdyssey Therapeutics
HQ
Boston, US
Employees
148↓ 1% decrease
Odyssey Therapeutics is a company that develops precision immunomodulators and oncology medicines.
View companyImmunoGen
HQ
Waltham, US
Employees
277
ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
View company